Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design (NCT07398417)
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy and Safety of AXS-14 in the Management of Fibromyalgia
🩺 Plain-English Summary (8th-Grade Level)
The study is a Phase 3, double-blind, placebo-controlled, randomized withdrawal study to assess the efficacy and safety of AXS-14 in the management of fibromyalgia.
Who can join: Review the eligibility criteria below.
Location: Clinical Research Site — Glendale, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (51 Sites)
Showing the first 25 of 51 sites.
- Clinical Research Site — Glendale, Arizona
- Clinical Research Site — Phoenix, Arizona
- Clinical Research Site — Tucson, Arizona
- Clinical Research Site — Little Rock, Arkansas
- Clinical Research Site — Anaheim, California
- Clinical Research Site — Oceanside, California
- Clinical Research Site — Redlands, California
- Clinical Research Site — Sacramento, California
- Clinical Research Site — Santa Ana, California
- Clinical Research Site — Cromwell, Connecticut
- Clinical Research Site — Hollywood, Florida
- Clinical Research Site — Jacksonville, Florida
- Clinical Research Site — Lakeland, Florida
- Clinical Research Site — Maitland, Florida
- Clinical Research Site — Orlando, Florida
- Clinical Research Site — Orlando, Florida
- Clinical Research Site — Tampa, Florida
- Clinical Research Site — The Villages, Florida
- Clinical Research Site — Atlanta, Georgia
- Clinical Research Site — Atlanta, Georgia
- Clinical Research Site — Marietta, Georgia
- Clinical Research Site — Norcross, Georgia
- Clinical Research Site — Chicago, Illinois
- Clinical Research Site — Tinley Park, Illinois
- Clinical Research Site — Overland Park, Kansas
📞 Contact the Study Coordinator
Phone: (212) 332-5061
Email: AXS-14-FM-301@axsome.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Fibromyalgia
- Virtual Specialty Clinic for Fibromyalgia Care — Covina, California
- A Study Of Virtual Reality Vs Sham VR On Fibromyalgia — Jacksonville, Florida
- Explosive Synchronization of Brain Network Activity in Chronic Pain — Ann Arbor, Michigan
- Microcurrent for Fibromyalgia — Nellis Air Force Base, Nevada
- Elucidating the Central Mechanisms of Action for Green Light Therapy in Managing Chronic Pain — Tucson, Arizona
- taVNS Treatment for Fibromyalgia — Charlestown, Massachusetts
Explore by condition: All Fibromyalgia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.